Strs Ohio Cue Biopharma, Inc. Transaction History

Strs Ohio

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 25, 2021	SELL	$11.12 - $16.4 $227,959 - $336,199	-20,500 Closed	0 $0
Q3 2020 Dec 14, 2020	SELL	$15.05 - $23.54 $66,220 - $103,576	-4,400 Reduced 17.67%	20,500 $308,000
Q2 2020 Jul 23, 2020	SELL	$12.7 - $30.73 $41,910 - $101,409	-3,300 Reduced 11.7%	24,900 $610,000
Q3 2019 Oct 21, 2019	BUY	$6.78 - $9.28 $89,496 - $122,495	13,200 Added 88.0%	28,200 $237,000
Q2 2019 Jul 25, 2019	BUY	$7.18 - $9.65 $89,750 - $120,625	12,500 Added 500.0%	15,000 $134,000
Q1 2018 Apr 20, 2018	BUY	$11.63 - $17.25 $29,075 - $43,125	2,500 New	2,500 $35,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.